Cargando…
Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial
BACKGROUND: Despite improvement in the standard of care (SOC) for hospitalized COVID-19 patients, rates of morbidity and mortality remain high. There continues to be a need for easily available and cost-effective treatments. Colchicine and rosuvastatin are both safe and well-studied medications with...
Autores principales: | Shah, Tayyab, McCarthy, Marianne, Nasir, Irem, Archer, Herb, Ragheb, Elio, Kluger, Jonathan, Kashyap, Nitu, Paredes, Carlos, Patel, Prashant, Lu, Jing, Kandel, Prakash, Song, Christopher, Khan, Mustafa, Ul Haq, Faheem, Ahmad, Rami, Howes, Christopher, Cambi, Brian, Lancaster, Gilead, Cleman, Michael, Dela Cruz, Charles S., Parise, Helen, Lansky, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397504/ https://www.ncbi.nlm.nih.gov/pubmed/34461322 http://dx.doi.org/10.1016/j.cct.2021.106547 |
Ejemplares similares
-
Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
por: Shah, Tayyab, et al.
Publicado: (2023) -
Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021) -
Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021) -
Colchicine
por: Ben-Chetrit, Eldad
Publicado: (2018) -
Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019)